Answers are grounded in this paper and cite their sources.
This review outlines the risks and benefits of percutaneous and transcatheter approaches for managing structural and coronary heart disease during pregnancy.
Pregnancy is associated with significant hemodynamic, tissue and hematic changes in the maternal cardiovascular system, which could result in worsening some previously asymptomatic cardiac conditions. Since the last 30 years, new techniques and devices have been introduced in the field of structural and coronary heart disease. In this review, we describe the balance between the risk and benefit of percutaneous therapy and the possibility of transcatheter approach to the most common heart disease during pregnancy.
No takes yet. Share an insight, caveat, or question.
Mennuni et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: